Rodino KG, Theel ES, Pritt BS. Tick-borne diseases in the United States. Clin Chem. 2020;66:537–48.
Article
Google Scholar
Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of lyme disease diagnoses, United States, 2010–2018. Emerg Infect Dis. 2021;27:616–9.
Article
Google Scholar
Mead PS. Epidemiology of Lyme disease. Infect Dis Clin N Am. 2015;29:187–210.
Article
Google Scholar
Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;151:1571–83.
Article
CAS
Google Scholar
Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, Fischer P. Secondary dementia due to Lyme neuroborreliosis. Wien Klin Wochenschr. 2018;130:468–78.
Article
Google Scholar
MacDonald AB. Borrelia in the brains of patients dying with dementia. JAMA. 1986;256:2195–6.
Article
CAS
Google Scholar
MacDonald AB, Miranda JM. Concurrent neocortical borreliosis and Alzheimer’s disease. Hum Pathol. 1987;18:759–61.
Article
CAS
Google Scholar
Cassarino DS, Quezado MM, Ghatak NR, Duray PH. Lyme-associated parkinsonism: a neuropathologic case study and review of the literature. Arch Pathol Lab Med. 2003;127:1204–6.
Article
Google Scholar
Waniek C, Prohovnik I, Kaufman MA, Dwork AJ. Rapidly progressive frontal-type dementia associated with Lyme disease. J Neuropsychiatry Clin Neurosci. 1995;7:345–7.
Article
CAS
Google Scholar
Gadila SKG, Rosoklija G, Dwork AJ, Fallon BA, Embers ME. Detecting Borrelia spirochetes: a case study with validation among autopsy specimens. Front Neurol. 2021;12: 628045.
Article
Google Scholar
Paradiso B, Zucchini S, Simonato M. Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. Front Cell Neurosci. 2013;7:152.
Article
CAS
Google Scholar
Terwisscha van Scheltinga AF, Bakker SC, Kahn RS. Fibroblast growth factors in schizophrenia. Schizophr Bull. 2010;36:1157–66.
Article
Google Scholar
Alam R, Mrad Y, Hammoud H, Saker Z, Fares Y, Estephan E, Bahmad HF, Harati H, Nabha S. New insights into the role of fibroblast growth factors in Alzheimer’s disease. Mol Biol Rep. 2022;49:1413–27.
Article
CAS
Google Scholar
Liu Y, Deng J, Liu Y, Li W, Nie X. FGF, mechanism of action, role in Parkinson’s disease, and therapeutics. Front Pharmacol. 2021;12: 675725.
Article
CAS
Google Scholar
Deng Z, Deng S, Zhang MR, Tang MM. Fibroblast growth factors in depression. Front Pharmacol. 2019;10:60.
Article
CAS
Google Scholar
Dordoe C, Chen K, Huang W, Chen J, Hu J, Wang X, Lin L. Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke. Front Pharmacol. 2021;12: 671131.
Article
CAS
Google Scholar
Rajendran R, Bottiger G, Stadelmann C, Karnati S, Berghoff M. FGF/FGFR pathways in multiple sclerosis and in its disease models. Cells. 2021;10:884.
Article
CAS
Google Scholar
Woodbury ME, Ikezu T. Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol. 2014;9:92–101.
Article
Google Scholar
Li S, Bock E, Berezin V. Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor. Int J Mol Sci. 2010;11:2291–305.
Article
CAS
Google Scholar
Cassina P, Pehar M, Vargas MR, Castellanos R, Barbeito AG, Estevez AG, Thompson JA, Beckman JS, Barbeito L. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem. 2005;93:38–46.
Article
CAS
Google Scholar
von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol. 2016;524:3865–95.
Article
Google Scholar
Parthasarathy G, Philipp MT. Inflammatory mediator release from primary rhesus microglia in response to Borrelia burgdorferi results from the activation of several receptors and pathways. J Neuroinflamm. 2015;12:60.
Article
Google Scholar
Parthasarathy G, Gadila SKG. Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo. Sci Rep. 2022;12:688.
Article
CAS
Google Scholar
Parthasarathy G, Philipp MT. Receptor tyrosine kinases play a significant role in human oligodendrocyte inflammation and cell death associated with the Lyme disease bacterium Borrelia burgdorferi. J Neuroinflamm. 2017;14:110.
Article
Google Scholar
Mohammadi M, Schlessinger J, Hubbard SR. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell. 1996;86:577–87.
Article
CAS
Google Scholar
Chell V, Balmanno K, Little AS, Wilson M, Andrews S, Blockley L, Hampson M, Gavine PR, Cook SJ. Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. Oncogene. 2013;32:3059–70.
Article
CAS
Google Scholar
Komla-Ebri D, Dambroise E, Kramer I, Benoist-Lasselin C, Kaci N, Le Gall C, Martin L, Busca P, Barbault F, Graus-Porta D, et al. Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model. J Clin Invest. 2016;126:1871–84.
Article
Google Scholar
Risuleo G, Ciacciarelli M, Castelli M, Galati G. The synthetic inhibitor of fibroblast growth factor receptor PD166866 controls negatively the growth of tumor cells in culture. J Exp Clin Cancer Res. 2009;28:151.
Article
Google Scholar
Ramesh G, Benge S, Pahar B, Philipp MT. A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. J Neuroinflamm. 2012;9:72.
Article
CAS
Google Scholar
Goldstein M, Meller I, Orr-Urtreger A. FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5′ CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes. Genes Chromosom Cancer. 2007;46:1028–38.
Article
CAS
Google Scholar
Chudasama P, Renner M, Straub M, Mughal SS, Hutter B, Kosaloglu Z, Schwessinger R, Scheffler M, Alldinger I, Schimmack S, et al. Targeting fibroblast growth factor receptor 1 for treatment of soft-tissue sarcoma. Clin Cancer Res. 2017;23:962–73.
Article
CAS
Google Scholar
Napolitano A, Ostler AE, Jones RL, Huang PH. Fibroblast growth factor receptor (FGFR) signaling in GIST and soft tissue sarcomas. Cells. 2021;10:1533.
Article
CAS
Google Scholar
Johannes L, Jacob R, Leffler H. Galectins at a glance. J Cell Sci. 2018;131: jcs208884.
Article
Google Scholar
Popa SJ, Stewart SE, Moreau K. Unconventional secretion of annexins and galectins. Semin Cell Dev Biol. 2018;83:42–50.
Article
CAS
Google Scholar
Kucinska M, Porebska N, Lampart A, Latko M, Knapik A, Zakrzewska M, Otlewski J, Opalinski L. Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins. Cell Commun Signal. 2019;17:65.
Article
Google Scholar
Siew JJ, Chen HM, Chen HY, Chen HL, Chen CM, Soong BW, Wu YR, Chang CP, Chan YC, Lin CH, et al. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease. Nat Commun. 2019;10:3473.
Article
Google Scholar
Terzuoli E, Corti F, Nannelli G, Giachetti A, Donnini S, Ziche M. Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1. Int J Mol Sci. 2018;19:2638.
Article
Google Scholar
Abbott NJ. Inflammatory mediators and modulation of blood–brain barrier permeability. Cell Mol Neurobiol. 2000;20:131–47.
Article
CAS
Google Scholar
Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T, Ifuku M, Kosai Y, Wang B, Nolte C, et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem. 2007;101:397–410.
Article
CAS
Google Scholar
Noda M, Kariura Y, Amano T, Manago Y, Nishikawa K, Aoki S, Wada K. Expression and function of bradykinin receptors in microglia. Life Sci. 2003;72:1573–81.
Article
CAS
Google Scholar
Socodato R, Portugal CC, Domith I, Oliveira NA, Coreixas VS, Loiola EC, Martins T, Santiago AR, Paes-de-Carvalho R, Ambrosio AF, Relvas JB. c-Src function is necessary and sufficient for triggering microglial cell activation. Glia. 2015;63:497–511.
Article
Google Scholar
Yang H, Wang L, Zang C, Wang Y, Shang J, Zhang Z, Liu H, Bao X, Wang X, Zhang D. Src inhibition attenuates neuroinflammation and protects dopaminergic neurons in Parkinson’s disease models. Front Neurosci. 2020;14:45.
Article
Google Scholar
Wawrzeniak K, Gaur G, Sapi E, Senejani AG. Effect of Borrelia burgdorferi outer membrane vesicles on host oxidative stress response. Antibiotics. 2020;9:275.
Article
CAS
Google Scholar
Sato S, Burdett I, Hughes RC. Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp Cell Res. 1993;207:8–18.
Article
CAS
Google Scholar
Xu Y, Tan Q, Hu P, Yao J. Characterization and expression analysis of FGF6 (fibroblast growth factor 6) genes of grass carp (Ctenopharyngodon idellus) reveal their regulation on muscle growth. Fish Physiol Biochem. 2019;45:1649–62.
Article
CAS
Google Scholar
Ozawa K, Uruno T, Miyakawa K, Seo M, Imamura T. Expression of the fibroblast growth factor family and their receptor family genes during mouse brain development. Brain Res Mol Brain Res. 1996;41:279–88.
Article
CAS
Google Scholar
Huang PY, Shih YH, Tseng YJ, Ko TL, Fu YS, Lin YY. Xenograft of human umbilical mesenchymal stem cells from Wharton’s jelly as a potential therapy for rat pilocarpine-induced epilepsy. Brain Behav Immun. 2016;54:45–58.
Article
CAS
Google Scholar
Sengul B, Dursun E, Verkhratsky A, Gezen-Ak D. Overexpression of alpha-synuclein reorganises growth factor profile of human astrocytes. Mol Neurobiol. 2021;58:184–203.
Article
CAS
Google Scholar
Chen J, Wang Z, Zheng Z, Chen Y, Khor S, Shi K, He Z, Wang Q, Zhao Y, Zhang H, et al. Neuron and microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-kappaB-dependent neuroinflammation to improve functional recovery after spinal cord injury. Cell Death Dis. 2017;8: e3090.
Article
Google Scholar
Fang M, Jiang S, Zhu J, Fu X, Hu Y, Pan S, Jiang H, Lin J, Yuan J, Li P, Lin Z. Protective effects of FGF10 on neurovascular unit in a rat model of neonatal hypoxic-ischemic brain injury. Exp Neurol. 2020;332: 113393.
Article
CAS
Google Scholar
Li YH, Fu HL, Tian ML, Wang YQ, Chen W, Cai LL, Zhou XH, Yuan HB. Neuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-kappaB-dependent neuroinflammation and activating PI3K/Akt survival signaling pathway in mice. Sci Rep. 2016;6:19869.
Article
CAS
Google Scholar
Sohn SH, Chung HS, Ko E, Jeong HJ, Kim SH, Jeong JH, Kim Y, Shin M, Hong M, Bae H. The genome-wide expression profile of Nelumbinis semen on lipopolysaccharide-stimulated BV-2 microglial cells. Biol Pharm Bull. 2009;32:1012–20.
Article
CAS
Google Scholar
Veliskova J, Marra C, Liu Y, Shekhar A, Park DS, Iatckova V, Xie Y, Fishman GI, Velisek L, Goldfarb M. Early onset epilepsy and sudden unexpected death in epilepsy with cardiac arrhythmia in mice carrying the early infantile epileptic encephalopathy 47 gain-of-function FHF1(FGF12) missense mutation. Epilepsia. 2021;62:1546–58.
Article
CAS
Google Scholar
Willemsen MH, Goel H, Verhoeven JS, Braakman HMH, de Leeuw N, Freeth A, Minassian BA. Epilepsy phenotype in individuals with chromosomal duplication encompassing FGF12. Epilepsia Open. 2020;5:301–6.
Article
Google Scholar
Evans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, Lopez JF, Thompson RC, Meng F, Stead JD, et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA. 2004;101:15506–11.
Article
CAS
Google Scholar
Smallwood PM, Munoz-Sanjuan I, Tong P, Macke JP, Hendry SH, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA. 1996;93:9850–7.
Article
CAS
Google Scholar
Olsen SK, Garbi M, Zampieri N, Eliseenkova AV, Ornitz DM, Goldfarb M, Mohammadi M. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J Biol Chem. 2003;278:34226–36.
Article
CAS
Google Scholar
Sochacka M, Opalinski L, Szymczyk J, Zimoch MB, Czyrek A, Krowarsch D, Otlewski J, Zakrzewska M. FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner. Cell Commun Signal. 2020;18:69.
Article
CAS
Google Scholar
Liu P, Chen L, Bai X, Karaplis A, Miao D, Gu N. Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23. Brain Res. 2011;1412:9–17.
Article
CAS
Google Scholar
Hensel N, Schon A, Konen T, Lubben V, Forthmann B, Baron O, Grothe C, Leifheit-Nestler M, Claus P, Haffner D. Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density. J Neurochem. 2016;137:756–69.
Article
CAS
Google Scholar
Yao XY, Li S, Zhang LG, Liu ZH, Bao JN, Wu ZY. Higher serum fibroblast growth factor-23 levels and the risk of stroke and its subtypes: evidence from a meta-analysis of prospective studies. J Stroke Cerebrovasc Dis. 2018;27:3076–83.
Article
Google Scholar
McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS, Seshadri S. Circulating fibroblast growth factor 23 levels and incident dementia: the Framingham heart study. PLoS ONE. 2019;14: e0213321.
Article
CAS
Google Scholar
Chen J, Wang X, Hu J, Du J, Dordoe C, Zhou Q, Huang W, Guo R, Han F, Guo K, et al. FGF20 protected against BBB disruption after traumatic brain injury by upregulating junction protein expression and inhibiting the inflammatory response. Front Pharmacol. 2020;11: 590669.
Article
CAS
Google Scholar
Kang K, Xu P, Wang M, Chunyu J, Sun X, Ren G, Xiao W, Li D. FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress. Biomed Pharmacother. 2020;129: 110439.
Article
CAS
Google Scholar
Wang D, Liu F, Zhu L, Lin P, Han F, Wang X, Tan X, Lin L, Xiong Y. FGF21 alleviates neuroinflammation following ischemic stroke by modulating the temporal and spatial dynamics of microglia/macrophages. J Neuroinflamm. 2020;17:257.
Article
CAS
Google Scholar
Wang Q, Yuan J, Yu Z, Lin L, Jiang Y, Cao Z, Zhuang P, Whalen MJ, Song B, Wang XJ, et al. FGF21 Attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice. Mol Neurobiol. 2018;55:4702–17.
Article
CAS
Google Scholar
Lehallier B, Essioux L, Gayan J, Alexandridis R, Nikolcheva T, Wyss-Coray T, Britschgi M, Alzheimer’s Disease Neuroimaging I. Combined plasma and cerebrospinal fluid signature for the prediction of midterm progression from mild cognitive impairment to Alzheimer disease. JAMA Neurol. 2016;73:203–12.
Article
Google Scholar
Allerstorfer S, Sonvilla G, Fischer H, Spiegl-Kreinecker S, Gauglhofer C, Setinek U, Czech T, Marosi C, Buchroithner J, Pichler J, et al. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene. 2008;27:4180–90.
Article
CAS
Google Scholar
Reuss B, Dono R, Unsicker K. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood–brain barrier permeability: evidence from mouse mutants. J Neurosci. 2003;23:6404–12.
Article
CAS
Google Scholar
van Vliet EA, da Costa AS, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007;130:521–34.
Article
Google Scholar
Terauchi A, Johnson-Venkatesh EM, Toth AB, Javed D, Sutton MA, Umemori H. Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature. 2010;465:783–7.
Article
CAS
Google Scholar
Schur RR, Draisma LW, Wijnen JP, Boks MP, Koevoets MG, Joels M, Klomp DW, Kahn RS, Vinkers CH. Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies. Hum Brain Mapp. 2016;37:3337–52.
Article
Google Scholar
Kalueff AV, Nutt DJ. Role of GABA in anxiety and depression. Depress Anxiety. 2007;24:495–517.
Article
CAS
Google Scholar
Nakamura S, Arima K, Haga S, Aizawa T, Motoi Y, Otsuka M, Ueki A, Ikeda K. Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques. Brain Res. 1998;814:222–5.
Article
CAS
Google Scholar
Aurbach EL, Inui EG, Turner CA, Hagenauer MH, Prater KE, Li JZ, Absher D, Shah N, Blandino P Jr, Bunney WE, et al. Fibroblast growth factor 9 is a novel modulator of negative affect. Proc Natl Acad Sci USA. 2015;112:11953–8.
Article
CAS
Google Scholar
Lee KW, Yim HS, Shin J, Lee C, Lee JH, Jeong JY. FGF11 induced by hypoxia interacts with HIF-1alpha and enhances its stability. FEBS Lett. 2017;591:348–57.
Article
CAS
Google Scholar
Zhu T, Zhan L, Liang D, Hu J, Lu Z, Zhu X, Sun W, Liu L, Xu E. Hypoxia-inducible factor 1alpha mediates neuroprotection of hypoxic postconditioning against global cerebral ischemia. J Neuropathol Exp Neurol. 2014;73:975–86.
Article
CAS
Google Scholar
Shen Y, Gu J, Liu Z, Xu C, Qian S, Zhang X, Zhou B, Guan Q, Sun Y, Wang Y, Jin X. Inhibition of HIF-1alpha reduced blood brain barrier damage by regulating MMP-2 and VEGF during acute cerebral ischemia. Front Cell Neurosci. 2018;12:288.
Article
Google Scholar
Li J, Wang Q, Wang H, Wu Y, Yin J, Chen J, Zheng Z, Jiang T, Xie L, Wu F, et al. Lentivirus mediating FGF13 enhances axon regeneration after spinal cord injury by stabilizing microtubule and improving mitochondrial function. J Neurotrauma. 2018;35:548–59.
Article
Google Scholar
Hu Y, Li L, Shen L, Gao H, Yu F, Yin W, Liu W. FGF-16 protects against adverse cardiac remodeling in the infarct diabetic heart. Am J Transl Res. 2017;9:1630–40.
CAS
Google Scholar
Miyake A, Chitose T, Kamei E, Murakami A, Nakayama Y, Konishi M, Itoh N. Fgf16 is required for specification of GABAergic neurons and oligodendrocytes in the zebrafish forebrain. PLoS ONE. 2014;9: e110836.
Article
Google Scholar
Boshoff EL, Fletcher EJR, Duty S. Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner. Neuropharmacology. 2018;137:156–63.
Article
CAS
Google Scholar
Amiri M, Braidy N, Aminzadeh M. Protective effects of fibroblast growth factor 21 against amyloid-beta1-42-induced toxicity in SH-SY5Y cells. Neurotox Res. 2018;34:574–83.
Article
CAS
Google Scholar
Chen S, Chen ST, Sun Y, Xu Z, Wang Y, Yao SY, Yao WB, Gao XD. Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer’s disease. Redox Biol. 2019;22: 101133.
Article
CAS
Google Scholar
Sun Y, Wang Y, Chen ST, Chen YJ, Shen J, Yao WB, Gao XD, Chen S. Modulation of the astrocyte-neuron lactate shuttle system contributes to neuroprotective action of fibroblast growth factor 21. Theranostics. 2020;10:8430–45.
Article
CAS
Google Scholar
Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4:215–66.
Article
CAS
Google Scholar